NPI: 1083644033 · WESTON, FL 33331 · General Acute Care Hospital · NPI assigned 07/04/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 07/04/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,385 | $48K |
| 2019 | 60,577 | $304K |
| 2020 | 58,888 | $370K |
| 2021 | 70,446 | $536K |
| 2022 | 55,644 | $541K |
| 2023 | 10,066 | $128K |
| 2024 | 310 | $7K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 4,045 | 2,644 | $293K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,715 | 5,892 | $288K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,567 | 2,908 | $208K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,998 | 1,591 | $152K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,983 | 1,738 | $108K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,044 | 815 | $76K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,835 | 1,472 | $76K |
| 82962 | 5,223 | 2,167 | $62K | |
| 36415 | Collection of venous blood by venipuncture | 22,530 | 12,375 | $59K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 724 | 585 | $59K |
| 80053 | Comprehensive metabolic panel | 21,687 | 13,005 | $50K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,021 | 3,089 | $40K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,927 | 2,303 | $39K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,821 | 1,423 | $36K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 657 | 511 | $31K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,263 | 934 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,569 | 2,331 | $20K |
| G0378 | Hospital observation service, per hour | 3,151 | 1,622 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,974 | 1,000 | $18K |
| 71046 | Radiologic examination, chest; 2 views | 1,961 | 1,551 | $16K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,161 | 1,677 | $16K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,767 | 1,350 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 23,742 | 13,565 | $14K |
| 84702 | 2,059 | 1,681 | $13K | |
| J2704 | Injection, propofol, 10 mg | 2,511 | 1,853 | $12K |
| 84484 | 3,884 | 2,608 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,790 | 2,970 | $11K |
| A9270 | Non-covered item or service | 3,303 | 1,636 | $9K |
| 71045 | Radiologic examination, chest; single view | 4,514 | 3,447 | $8K |
| 71250 | 591 | 459 | $8K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 107 | 100 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,391 | 2,405 | $7K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 49 | 43 | $7K |
| 86850 | 1,731 | 1,333 | $7K | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,245 | 1,041 | $7K |
| 81001 | 11,640 | 6,807 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 215 | 162 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,865 | 3,608 | $5K |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 2,592 | 1,638 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 361 | 288 | $4K |
| 87497 | 3,867 | 2,587 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 103 | 87 | $4K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 119 | 101 | $3K |
| 84100 | 8,534 | 3,717 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,115 | 2,362 | $3K |
| 83735 | 9,914 | 4,571 | $3K | |
| 85610 | 3,506 | 2,592 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,274 | 3,771 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 479 | 377 | $3K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,633 | 1,066 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 606 | 380 | $3K |
| 80197 | 7,641 | 3,156 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 149 | 73 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 497 | 436 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 534 | 382 | $2K |
| 82570 | 7,574 | 3,678 | $2K | |
| 76830 | Ultrasound, transvaginal | 73 | 67 | $2K |
| 83615 | 5,263 | 2,334 | $2K | |
| 84156 | 6,628 | 3,002 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,561 | 1,734 | $2K |
| 86900 | 1,728 | 1,332 | $2K | |
| 82040 | 601 | 443 | $2K | |
| 82043 | 4,383 | 2,293 | $2K | |
| 87077 | 1,102 | 773 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 536 | 347 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 693 | 533 | $1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 49 | 41 | $1K |
| C1769 | Guide wire | 19 | 14 | $1K |
| 82550 | 1,705 | 1,193 | $1K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 704 | 555 | $1K |
| 83605 | 1,009 | 738 | $1K | |
| 86901 | 1,727 | 1,331 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 291 | 250 | $1K |
| 77080 | 178 | 137 | $1K | |
| 87799 | 3,838 | 2,505 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 206 | 143 | $995.58 |
| 96376 | 1,274 | 651 | $990.06 | |
| 83880 | 1,474 | 1,105 | $947.25 | |
| 83690 | 3,018 | 2,315 | $932.43 | |
| 80061 | Lipid panel | 3,055 | 2,335 | $864.42 |
| 86140 | 2,064 | 1,619 | $775.99 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,970 | 1,482 | $764.77 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,976 | 1,444 | $763.60 |
| 87040 | 916 | 654 | $726.43 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 32 | 25 | $667.41 |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,486 | 1,876 | $642.07 |
| 85730 | 1,412 | 1,055 | $611.94 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 198 | 157 | $543.14 |
| 36430 | 19 | 13 | $507.56 | |
| 97161 | 75 | 57 | $490.13 | |
| 99152 | 270 | 194 | $480.19 | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 19 | 12 | $453.56 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 970 | 651 | $398.58 |
| 82607 | 1,022 | 772 | $339.03 | |
| 84550 | 443 | 307 | $311.76 | |
| 0240U | 89 | 81 | $278.73 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,209 | 1,771 | $267.34 |
| 72125 | Computed tomography, cervical spine; without contrast material | 141 | 105 | $241.72 |
| 76770 | 15 | 12 | $235.77 | |
| 83540 | 880 | 642 | $223.10 | |
| 87186 | 826 | 566 | $217.45 | |
| 82728 | 758 | 549 | $206.80 | |
| 83550 | 809 | 590 | $202.12 | |
| 84155 | 502 | 384 | $195.88 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 502 | 278 | $192.70 |
| 83970 | 465 | 339 | $185.63 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 596 | 409 | $182.40 |
| 85652 | 716 | 554 | $182.25 | |
| 82247 | 473 | 354 | $175.46 | |
| 73630 | 17 | 12 | $164.88 | |
| 84439 | 677 | 517 | $150.63 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 37 | 28 | $150.00 |
| 93296 | 17 | 15 | $136.25 | |
| 82553 | 451 | 313 | $134.94 | |
| 84075 | 339 | 263 | $80.43 | |
| 93971 | 18 | 15 | $78.89 | |
| 87070 | 42 | 36 | $76.99 | |
| 72100 | 13 | 12 | $61.85 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 37 | 27 | $56.37 |
| 82746 | 145 | 110 | $55.66 | |
| 84295 | 122 | 90 | $45.17 | |
| 82248 | 70 | 48 | $9.99 | |
| 85379 | 409 | 327 | $9.27 | |
| 81003 | 380 | 284 | $2.12 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 170 | 139 | $1.25 |
| 81025 | 15 | 14 | $0.88 | |
| 99153 | Mod sedat endo service >5yrs | 31 | 24 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 17 | 14 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 16 | 12 | $0.00 |
| 85027 | 19 | 14 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 14 | 12 | $0.00 |
| 94760 | 57 | 40 | $0.00 | |
| 80069 | 18 | 12 | $0.00 | |
| 87340 | 17 | 12 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 19 | 12 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 24 | 18 | $0.00 |
| 82947 | 68 | 52 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 38 | 27 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 16 | 12 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 48 | 37 | $0.00 |
| 84145 | 51 | 38 | $0.00 | |
| 82565 | 49 | 37 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | 13 | $0.00 |
| 84460 | 57 | 43 | $0.00 | |
| 86923 | 19 | 12 | $0.00 | |
| 93970 | 17 | 13 | $0.00 | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 18 | 13 | $0.00 |